USANA Health Sciences Inc
$ 19.44
1.04%
24 Apr - close price
- Market Cap 358,803,000 USD
- Current Price $ 19.44
- High / Low $ 19.52 / 19.16
- Stock P/E 33.52
- Book Value 29.16
- EPS 0.58
- Next Earning Report 2026-05-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.02 %
- 52 Week High 38.32
- 52 Week Low 16.60
About
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah.
Analyst Target Price
$39.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-17 | 2025-11-05 | 2025-07-21 | 2025-04-28 | 2025-02-04 | 2024-10-22 | 2024-07-23 | 2024-04-30 | 2024-02-06 | 2023-10-24 | 2023-07-25 | 2023-04-25 |
| Reported EPS | 0.6 | -0.36 | 0.74 | 0.73 | 0.64 | 0.56 | 0.54 | 0.86 | 0.87 | 0.59 | 0.89 | 0.95 |
| Estimated EPS | 0.4 | 0.56 | 0.54 | 0.7 | 0.49 | 0.49 | 0.65 | 0.69 | 0.52 | 0.64 | 0.7 | 0.77 |
| Surprise | 0.2 | -0.92 | 0.2 | 0.03 | 0.15 | 0.07 | -0.11 | 0.17 | 0.35 | -0.05 | 0.19 | 0.18 |
| Surprise Percentage | 50% | -164.2857% | 37.037% | 4.2857% | 30.6122% | 14.2857% | -16.9231% | 24.6377% | 67.3077% | -7.8125% | 27.1429% | 23.3766% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.44 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: USNA
2026-04-24 11:10:21
Zacks Research has downgraded USANA Health Sciences (NYSE:USNA) from a "strong-buy" to a "hold" rating, reflecting mixed analyst views on the company. Despite beating Q4 EPS estimates and meeting revenue expectations, the stock, currently trading around $19, faces a "Reduce" average rating from MarketBeat data, though some institutional investors have recently increased their positions.
2026-04-22 23:39:42
USANA Malaysia launched its new Vitamin D supplement with a large-scale acupressure slow jogging event, which earned a Malaysia Book of Records title for "Most Participants in a Simultaneous Acupressure Slow Jogging Event." The event gathered over 1,000 participants and aimed to promote healthier lifestyles and raise awareness about Vitamin D deficiency in Malaysia, where over 65% of the population is deficient despite abundant sunlight. This initiative reinforces USANA's commitment to community wellness and health education.
2026-04-22 11:39:12
Sidoti has decreased its Q3 2026 earnings per share estimates for USANA Health Sciences (NYSE:USNA) to $0.43, down from $0.45. This comes after USANA Health Sciences outperformed previous consensus estimates in its Q4 earnings report, posting $0.60 EPS against an expected $0.41. The company's stock currently holds a "Moderate Buy" rating from analysts.
2026-04-15 11:40:13
Zacks Research upgraded USANA Health Sciences (NYSE:USNA) to a "strong-buy" rating. This upgrade comes as the company continues to have mixed analyst ratings, with an overall consensus of "Moderate Buy." USANA recently beat quarterly EPS estimates and its stock currently trades around $18.50 with a market capitalization of $341.51 million.
2026-04-15 10:40:13
USANA Health Sciences, Inc. (NYSE:USNA) announced its first quarter 2026 earnings will be released on Tuesday, May 5, 2026, after market close. A Management Commentary document will be posted on their Investor Relations website, followed by a conference call for analysts and institutional investors on Wednesday, May 6, 2026, at 11:00 a.m. Eastern Time. The call will also be accessible via webcast on the company's IR website.
2026-04-15 07:00:00
USANA Health Sciences, Inc. (NYSE: USNA) announced its first-quarter 2026 earnings will be released after market close on Tuesday, May 5, 2026. A Management Commentary document will be posted on its Investor Relations website, and a conference call for analysts and institutional investors will be held the following morning, Wednesday, May 6, 2026, at 11:00 a.m. Eastern Time. USANA develops and manufactures nutritional supplements, functional foods, and personal care products, and holds ownership stakes in Hiya Health Products and Rise Wellness.
